comprehensive -WSS

comprehensive

author：hotspot 2025-09-07 17:19:59 - browse：8

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： FDA approves first treatment for ultra

focus

WSS

Hospitals are piloting generative AI tools as regulators play catch

New CMS data security rules will hurt Medicare, Medicaid research

FDA approves first treatment for ultra

Baltimore teen accused of firing into crowd during block party mass shooting

The pain doctors face in trying to build their families

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Wikipedia

comprehensive

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Researchers tackle phage therapy hurdles for wider adoption

In Memoriam: Notable people who died in 2023

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

In age of alternative facts, a scholarly course on calling out crap

As Maui death toll rises, number of missing remains unclear

DIEP, the 'gold standard' of breast reconstruction, is under threat

Abridge raises $150m as clinical notes automation market heats up

BioMarin wins approval for gene therapy to treat hemophilia A

Weight loss drugs aren’t covered by Obamacare. That may change

explore

Reporting on presidential health from Reagan to Trump and Biden

Listen: Racing for gene therapy & a pioneering approval

FDA approves first treatment for ultra

New CMS data security rules will hurt Medicare, Medicaid research

FDA warns medical device makers about rise in fabricated data

New study raises questions about niacin and heart health

focus

focus

focus

hotspot